Enveric clears FDA feedback milestone, prepares IND submission for EB-003
IND application for EB-003 expected in early 2026
IND application for EB-003 expected in early 2026
Announces pilot project for rapid, remote diagnosis of tuberculosis
Both parties are expected to invest a total of US $ 1 million to establish the brand
Guidelines aim to establish state-regulated veterinary blood banks
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
Subscribe To Our Newsletter & Stay Updated